Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIROL: Terlipressin for Renal Outcome After Liver Surgery
NCT02368249Phase 2Withdrawn
- Sponsor
- University of Zurich
- Start
- Jan 2020
- Primary completion
- Feb 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terlipressin in acute kidney injury (AKI), sponsored by University of Zurich. Planned start Jan 2020; status: withdrawn.
02
Drugs
terlipressin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02368249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368249.